KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Other financing activities (2018 - 2019)

Adaptive Biotechnologies' Other financing activities history spans 2 years, with the latest figure at $5.0 million for Q4 2019.

  • For Q4 2019, Other financing activities rose 27655.56% year-over-year to $5.0 million; the TTM value through Dec 2020 reached $5.0 million, changed 0.12%, while the annual FY2020 figure was $321000.0, 93.56% down from the prior year.
  • Other financing activities for Q4 2019 was $5.0 million at Adaptive Biotechnologies, up from -$1000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $5.0 million in Q4 2019 and bottomed at -$6000.0 in Q1 2019.